ArticleMolecular therapy oncolytics2021

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation.

Kotaro Sugawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.